Literature DB >> 18253106

Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning.

Wolfgang A Weber1, Anca L Grosu, Johannes Czernin.   

Abstract

PET/CT imaging has rapidly emerged as an important imaging tool in oncology. The success of PET/CT imaging is based on several features. First, patients benefit from a comprehensive diagnostic anatomical and functional (molecular) whole-body survey in a single session. Second, PET/CT provides more-accurate diagnostic information than PET or CT alone. Third, PET/CT imaging allows radiation oncologists to use the functional information provided by PET scans for radiation treatment planning. In this Review we discuss the technical features of PET/CT, its economic aspects within the health-care system, and its role in diagnosis, staging, restaging and treatment monitoring as well as radiation planning in patients with cancer.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18253106     DOI： 10.1038/ncponc1041

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


  36 in total

1.  The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.

Authors:  Martin Fuchs; Matthias Briel; Thomas Daikeler; Ulrich A Walker; Helmut Rasch; Scott Berg; Quinn K T Ng; Heike Raatz; David Jayne; Ina Kötter; Daniel Blockmans; Maria C Cid; Sergio Prieto-González; Peter Lamprecht; Carlo Salvarani; Zaharenia Karageorgaki; Richard Watts; Raashid Luqmani; Jan Müller-Brand; Alan Tyndall; Martin A Walter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

Review 2.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  [In vivo imaging of retinal cell apoptosis following acute light exposure].

Authors:  S Schmitz-Valckenberg; L Guo; W Cheung; S E Moss; F W Fitzke; M F Cordeiro
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

4.  Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.

Authors:  Michael Souvatzoglou; Matthias Eiber; Toshiki Takei; Sebastian Fürst; Tobias Maurer; Florian Gaertner; Hans Geinitz; Alexander Drzezga; Sibylle Ziegler; Stephan G Nekolla; Ernst J Rummeny; Markus Schwaiger; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-02       Impact factor: 9.236

Review 5.  PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Authors:  Michael Souvatzoglou; Matthias Eiber; Axel Martinez-Moeller; Sebastian Fürst; Konstantin Holzapfel; Tobias Maurer; Sibylle Ziegler; Stephan Nekolla; Markus Schwaiger; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-24       Impact factor: 9.236

6.  DOI-based reconstruction algorithms for a compact breast PET scanner.

Authors:  Kyle M Champley; Lawrence R MacDonald; Thomas K Lewellen; Robert S Miyaoka; Paul E Kinahan
Journal:  Med Phys       Date:  2011-03       Impact factor: 4.071

7.  Effects of MR surface coils on PET quantification.

Authors:  Lawrence R MacDonald; Steve Kohlmyer; Chi Liu; Thomas K Lewellen; Paul E Kinahan
Journal:  Med Phys       Date:  2011-06       Impact factor: 4.071

Review 8.  Functional imaging of renal cell carcinoma.

Authors:  Nathan Lawrentschuk; Ian D Davis; Damien M Bolton; Andrew M Scott
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

Review 9.  Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature.

Authors:  Rubel Chakravarty; Hao Hong; Weibo Cai
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

10.  Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.

Authors:  Robert K Doot; Larry A Pierce; Darrin Byrd; Brian Elston; Keith C Allberg; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.